SCHEMBL4688976

SCHEMBL4688976

NC(=O)c1ccc(OC[C@@H](O)CO)c(Cl)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 3/20 0.44
LMNA P02545 3/20 0.44
AGTR1 P30556 1/20 0.44
MRGPRX4 Q96LA9 1/20 0.43
NPSR1 Q6W5P4 1/20 0.42
CYP2D6 P10635 1/20 0.42
SLC6A2 P23975 1/20 0.41
SLC6A4 P31645 1/20 0.41
SLC6A3 Q01959 1/20 0.41
TAS1R3 Q7RTX0 1/20 0.41
TAS1R1 Q7RTX1 1/20 0.41
MAPK1 P28482 1/20 0.41
KDM4E B2RXH2 1/20 0.41
NPC1 O15118 1/20 0.41
HPGD P15428 1/20 0.41
RAB9A P51151 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
HTT P42858 1/20 0.40
MAPT P10636 1/20 0.40
MEN1 O00255 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4688980 1.00 CYP1A2 (0.44) CYP1A2LMNAAGTR1MRGPRX4NPSR1
SCHEMBL14763255 0.83 CYP1A2 (0.42) CYP1A2LMNAAGTR1NPSR1CYP2D6
SCHEMBL14763253 0.83 CYP1A2 (0.42) CYP1A2LMNAAGTR1NPSR1CYP2D6
SCHEMBL4685166 0.83 KDM4E (0.55) CYP1A2AGTR1KDM4EVDR
SCHEMBL6087260 0.83 CYP1A2 (0.59) CYP1A2LMNAAGTR1MAPK1KDM4E
SCHEMBL4685164 0.83 KDM4E (0.55) CYP1A2AGTR1KDM4EVDR
SCHEMBL9448494 0.83 KDM4E (0.55) CYP1A2AGTR1KDM4EVDR
SCHEMBL6087221 0.82 MAPK1 (0.65) CYP1A2LMNAAGTR1MAPK1KDM4E
SCHEMBL6087272 0.80 CYP1A2 (0.55) CYP1A2LMNAAGTR1MAPK1KDM4E
SCHEMBL4687860 0.79 MRGPRX4 (0.46) LMNAMRGPRX4NPSR1SLC6A2SLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1805163-B1 1,1A,5,5A-TETRAHYDRO-3-THIA-CYCLOPROPA[A]PENTALENES: TRICYCLIC THIOPHENE DERIVATIVES AS S1P1/EDG1 RECEPTOR AGONISTS ACTELION PHARMACEUTICALS LTD (CH) 2008-10-01 EP claimed